BR0303794A - Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation - Google Patents

Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation

Info

Publication number
BR0303794A
BR0303794A BR0303794-0A BR0303794A BR0303794A BR 0303794 A BR0303794 A BR 0303794A BR 0303794 A BR0303794 A BR 0303794A BR 0303794 A BR0303794 A BR 0303794A
Authority
BR
Brazil
Prior art keywords
medication
association
kit
medicinal products
medicaments
Prior art date
Application number
BR0303794-0A
Other languages
Portuguese (pt)
Inventor
Alexandre Funari Negrao
Original Assignee
Medley S A Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medley S A Ind Farmaceutica filed Critical Medley S A Ind Farmaceutica
Priority to BR0303794-0A priority Critical patent/BR0303794A/en
Priority to PCT/BR2004/000166 priority patent/WO2005023306A2/en
Publication of BR0303794A publication Critical patent/BR0303794A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MEDICAMENTO, KIT DE MEDICAMENTOS, CONJUNTO DE MEDICAMENTOS, ASSOCIAçãO MEDICAMENTOSA E MEDICAMENTO APRESENTANDO FORMA DE APRESENTAçãO FACILITADA". A presente invenção trata de conjunto de medicamentos, associação medicamentosa, medicamento e medicamento apresentando forma de apresentação facilitada compreendendo de forma individualizada e ao mesmo tempo conjunta: - uma ou mais unidades medicamentosas contendo princípio ativo lansoprazol, seus derivados ou sais farmaceuticamente aceitáveis; - uma ou mais unidades medicamentosas contendo princípio ativo domperidona, seus derivados ou sais farmaceuticamente aceitáveis; e opcionahnente outros aditivos ou drogas conhecidos do homem da técnica em veículo ou excipiente também farmaceuticamente aceitáveis."MEDICINAL PRODUCTS, MEDICINAL PRODUCTS KIT, MEDICINAL PRODUCTS ASSEMBLY, MEDICINAL ASSOCIATION AND MEDICINAL PRODUCTS PRESENTING EASY PRESENTATION". The present invention relates to a set of medicaments, drug combinations, medicaments and medicaments having a facilitated presentation comprising individually and at the same time together: - one or more pharmaceutical units containing active ingredient lansoprazole, its derivatives or pharmaceutically acceptable salts; - one or more pharmaceutical units containing active ingredient domperidone, its pharmaceutically acceptable derivatives or salts; and optionally other additives or drugs known to the person skilled in the art in a pharmaceutically acceptable carrier or excipient.

BR0303794-0A 2003-09-05 2003-09-05 Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation BR0303794A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR0303794-0A BR0303794A (en) 2003-09-05 2003-09-05 Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation
PCT/BR2004/000166 WO2005023306A2 (en) 2003-09-05 2004-09-03 Combination of medicaments comprising lansoprazole and domperidone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0303794-0A BR0303794A (en) 2003-09-05 2003-09-05 Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation

Publications (1)

Publication Number Publication Date
BR0303794A true BR0303794A (en) 2005-04-12

Family

ID=34230443

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0303794-0A BR0303794A (en) 2003-09-05 2003-09-05 Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation

Country Status (2)

Country Link
BR (1) BR0303794A (en)
WO (1) WO2005023306A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011136750A1 (en) * 2010-04-26 2011-11-03 Mahmut Bilgic Pharmaceutical compositions inducing synergistic effect

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089414A2 (en) * 2003-04-08 2004-10-21 Medley S.A. Indústria Farmacêutica Combinations of proton pump inhibitors or blockers with prokinetic agents

Also Published As

Publication number Publication date
WO2005023306A2 (en) 2005-03-17
WO2005023306A3 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
ATE306266T1 (en) IMPROVED ADMINISTRATION TECHNOLOGY FOR MULTIPLE MEDICATION DOSAGE
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
ATE509616T1 (en) TOPICAL PHARMACEUTICAL AND/OR COSMETIC DOSAGE SYSTEMS
AR029159A1 (en) PHARMACEUTICAL PREPARATION, PACKAGE CONTAINING AND USE IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT IN HORMONAL REPLACEMENT THERAPY
RU2009116834A (en) METHOD FOR ADMINISTRATION OF MEDICINES FOR REDUCING WEIGHT
NO20022058D0 (en) Pharmaceutical compositions
WO2006063189A3 (en) Multi-layered chewing gum tablet with quick disintegration layer
WO2005046640A3 (en) Multi-site drug delivery platform
JP2010525050A5 (en)
BRPI0513455A (en) flavor masking formulation comprising the drug in a delayed dissolution form and / or cyclodextrin in an improved dissolution form
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
AR025938A1 (en) NEW PHARMACEUTICAL COMPOSITIONS.
CY1112964T1 (en) KIT FOR PHARMACEUTICAL USE
BR0014826A (en) Bicyclic imidazo-3-yl-amines, their preparation procedure and medications containing them
WO2006060325A3 (en) Coated drug delivery formulations
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
BRPI0510855A (en) medicament in film form for oral administration and use of pharmaceutically acceptable estriol and / or estriol esters
AR022621A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DEOXIPEGANINE FOR THE TREATMENT OF NICOTINE DEPENDENCE
BR0303794A (en) Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation
BRPI0413374A (en) weak base release compositions for an extended period of time
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
Citrome New antipsychotic medications: what advantages do they offer?
MY141008A (en) Oral formulations of deoxypeganine and their uses
DE50005282D1 (en) MEDICINE AND MATCHED COMBINATION OF MEDICINES
BRPI0401556A (en) Medicine set, drug association and medicine

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MEDLEY INDUSTRIA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADO DE: MEDLEY S.A. INDUSTRIA FARMACEUTICA

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11, 13, 10, 24 E 25 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.